Introduction
Clear definitions concerning the biological differences between "cell ageing" and "cell senescence" are often lacking and not well defined. To those unfamiliar with the subject of cellular senescence, such terminology can lead to confusion. We have attempted to briefly clarify such differences as follows. Cellular ageing results from stochastic processes as a result of gradual accumulating damage over time, whereas cellular senescence is a programmed change in cell state associated with permanent growth inhibition. Aged cells maintain their normal function, albeit at a decreased capacity, whereas senescent cells acquire new functions.
In cell cultures of actively proliferating cells, senescence can be abruptly induced in a matter of days. However, in many tissues and organs which consist primarily of quiescent cells (reversible growth arrest) senescence induction can only occur once cells re-enter the cell cycle. The senescent state is often mediated by a persistent DNA damage response (DDR) (Burton and Faragher, 2015; d'Adda di Fagagna, 2008) , induced by stress induced stimuli such as telomere dysfunction, oncogene activation, oxidative stress, cell-cell fusion and chemotherapeutic drugs (Chuprin et al., 2013; Di Micco et al., 2006; Ewald et al., 2010; Toussaint et al., 2002; Victorelli and Passos, 2017) . "Induction" of senescence therefor refers to the programmed responses which occur following a DDR triggered by a stress induced stimuli. In addition to permanent growth arrest, the senescent state is accompanied by several additional phenotypic changes which make them distinct from their non-senescent counterparts (Table 1) . Although a senescence-like response has been reported in post-mitotic cells such as neurons (Jurk et al., 2012) , this review will focus on cell senescence in growth-competent cells.
Probably the most widely researched aspect of the senescent phenotype to date is the altered secretory response, referred to as the senescence-messaging secretome, senescence-associated secretory phenotype or the senescence-associated secretome (Campisi and d'Adda di Fagagna, 2007; Kuilman and Peeper, 2009; Malaquin et al., 2016) . Here we refer to this response simply as the "senescent secretome". The senescent program is often accompanied with transcriptional changes linked to an altered secretome, consisting of pro-inflammatory cytokines, growth factors and proteases which appear to mimic inflammatory wound repair processes (Coppé et al., 2008; Shelton et al., 1999) . In fact, senescent cells have been shown to be important in wound healing, tissue plasticity and tissue regeneration (Demaria et al., 2014; Mosteiro et al., 2016; Ritschka et al., 2017) , suggesting that such a secretome is likely physiologically important for such processes. However, to date, the senescent secretome has more often been considered from a pathological perspective, with emphasis being placed on the damaging effects of chronic inflammation in age-related diseases and cancer. In recent years there has been a surge of review articles
